🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06837844
Recruiting Not applicable

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

NCT06837844 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-02-20
Last updated
2025-02-21

Condition(s) studied

Intrathecal DexmedetomidineAdductor Canal BlockAnalgesiaTotal Knee Arthroplasty

Investigational drug(s) / intervention(s)

Intrathecal Dexmedetomidine →Adductor Canal BlockIntrathecal Dexmedetomidine + Adductor Canal Block →

Intrathecal Dexmedetomidine: Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 5 μg in 0.5ml dexmedetomidine + adductor canal block using 20 ml saline 0.9% at the end of surgery

Adductor Canal Block: Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 0.5ml saline 0.9% + adductor canal block using 20 ml bupivacaine 0.25% at the end of surgery.

Intrathecal Dexmedetomidine + Adductor Canal Block: Patients will receive 15mg in 3ml hyperbaric bupivacaine intrathecally with 5 μg in 0.5ml dexmedetomidine + adductor canal block using 20 ml bupivacaine 0.25% at the end of surgery.

Study summary

The aim of this work is to evaluate the effect of combined intrathecal dexmedetomidine and adductor canal block for analgesia after total knee arthroplasty (TKA).

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Age from 18 to 75 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Scheduled for total knee arthroplasty under spinal anesthesia. Exclusion Criteria: * Patients with neurological or intellectual disability. * History of allergy to local anesthetics or dexmedetomidine . * Infection at the injection site. * Prolonged use of analgesic or sedative medications. * Coagulation abnormalities. * Pregnancy. * Obesity \[body mass index (BMI) \> 30 kg/m2\].

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kafrelsheikh University Kafr ash Shaykh Kafrelsheikh Recruiting

More Kafrelsheikh University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06837844 on ClinicalTrials.gov ↗ ← All trials in Egypt